Specific genetic mutations: Identifying changes in genes related to drug metabolism, such as CYP2C19 and CYP3A4. Patient drug response: Evaluating whether the patient is a "good responder," "normal responder," or "poor responder" to anxiolytics and hypnotics. Potential side effects: Providing information on the possible risks of experiencing unwanted side effects. Drug interactions: Determining how other medications may interfere with the effectiveness of anxiolytics and hypnotics.

Patients receiving anxiolytics or hypnotics: To determine how their bodies respond to the medications used in treatment. Individuals experiencing side effects: To help identify genetic predispositions that may cause adverse reactions to the medications. Patients who do not respond to current treatment: To guide physicians toward more effective treatment options based on genetic background. Individuals with a family history of adverse drug reactions: To assess risks based on hereditary factors. Patients taking multiple medications: To ensure no negative interactions affect the effectiveness of anxiolytics and hypnotics.

Ineffective treatment response: When anxiolytics or hypnotics do not achieve the desired effect in relieving symptoms. Severe or unexpected side effects: Such as excessive dizziness, excessive drowsiness, or mood changes appearing after starting treatment. Family history of adverse drug reactions: If family members have experienced serious side effects from anxiolytics or hypnotics. Sudden changes in mental state: Such as worsening symptoms or the appearance of new symptoms after starting treatment. Concerns about drug interactions: Especially if the patient is taking multiple medications that may interfere with the effectiveness of anxiolytics and hypnotics.

What is pharmacogenetic testing for anxiolytics and hypnotics? It is a test used to determine how genetic variations affect an individual’s response to these medications. Why is this test performed? It is conducted to improve treatment effectiveness, personalize medication choices, and reduce side effects. How is the test performed? A blood or saliva sample is collected and analyzed in a specialized laboratory. Are there any special preparations before the test? Usually, no special preparations are required, but it is advisable to consult the physician regarding any medications that should be avoided. What results can be expected? The results may show genetic variations affecting the patient’s response to medications, which can help in personalizing treatment. Can treatment be changed based on the results? Yes, the results can be used to adjust dosages or select different medications. Are there any risks associated with this test? There are no major risks, although the patient may feel discomfort when the blood sample is taken. How long does it take to get the results? Results are usually available within days to weeks, depending on the laboratory.

Presence or absence of genetic variations: such as genes involved in drug metabolism (e.g., CYP2C19 and CYP3A4). Treatment response classifications: such as "good responder," "average responder," or "poor responder." Risk assessment: determining the potential risk of side effects based on the genetic makeup.

Anxiolytics Genetic Test | Lahalak Platform

This test reveals how your body responds to anxiety and sleep medications, helping select the most effective treatment to enhance efficacy, reduce side effects, and support well-being.

Prices starts from: 1224.4 SAR

Scientific name: Pharmacogenetic Testing for Anxiolytics and Hypnotics

Pharmacogenetic Testing for Anxiolytics and Hypnotics is a medical test aimed at examining genetic variations that affect how the body responds to anxiolytics and sedatives. A sample of blood or saliva is collected, and specific genes related to the metabolism of these medications are analyzed. This test helps doctors identify the most effective me...

Pharmacogenetic Testing for Anxiolytics and Hypnotics - Personalized Calm & Sleep Genetic Test

Service type Genetic test (Blood or Saliva)

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 1224.4 SAR

Included Services

Pharmacogenetic Testing for Anxiolytics and Hypnotics Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Specific genetic mutations: Identifying changes in genes related to drug metabolism, such as CYP2C19 and CYP3A4.
Patient drug response: Evaluating whether the patient is a "good responder," "normal responder," or "poor responder" to anxiolytics and hypnotics.
Potential side effects: Providing information on the possible risks of experiencing unwanted side effects.
Drug interactions: Determining how other medications may interfere with the effectiveness of anxiolytics and hypnotics.

Recommended groups

Patients receiving anxiolytics or hypnotics: To determine how their bodies respond to the medications used in treatment.
Individuals experiencing side effects: To help identify genetic predispositions that may cause adverse reactions to the medications.
Patients who do not respond to current treatment: To guide physicians toward more effective treatment options based on genetic background.
Individuals with a family history of adverse drug reactions: To assess risks based on hereditary factors.
Patients taking multiple medications: To ensure no negative interactions affect the effectiveness of anxiolytics and hypnotics.

Symptoms indicative

Ineffective treatment response: When anxiolytics or hypnotics do not achieve the desired effect in relieving symptoms.
Severe or unexpected side effects: Such as excessive dizziness, excessive drowsiness, or mood changes appearing after starting treatment.
Family history of adverse drug reactions: If family members have experienced serious side effects from anxiolytics or hypnotics.
Sudden changes in mental state: Such as worsening symptoms or the appearance of new symptoms after starting treatment.
Concerns about drug interactions: Especially if the patient is taking multiple medications that may interfere with the effectiveness of anxiolytics and hypnotics.

FAQs

What is pharmacogenetic testing for anxiolytics and hypnotics? It is a test used to determine how genetic variations affect an individual’s response to these medications.
Why is this test performed? It is conducted to improve treatment effectiveness, personalize medication choices, and reduce side effects.
How is the test performed? A blood or saliva sample is collected and analyzed in a specialized laboratory.
Are there any special preparations before the test? Usually, no special preparations are required, but it is advisable to consult the physician regarding any medications that should be avoided.
What results can be expected? The results may show genetic variations affecting the patient’s response to medications, which can help in personalizing treatment.
Can treatment be changed based on the results? Yes, the results can be used to adjust dosages or select different medications.

Normal Levels

Presence or absence of genetic variations: such as genes involved in drug metabolism (e.g., CYP2C19 and CYP3A4).
Treatment response classifications: such as "good responder," "average responder," or "poor responder."
Risk assessment: determining the potential risk of side effects based on the genetic makeup.